No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Insulin Efsitora is Noninferior to Degludec in Type 2 Diabetes without Previous Insulin Treatment

byAstrid BradshawandAlisha Yi

September 25, 2024

in StudyGraphics

Reading Time: 1 min read

#VisualAbstract: Insulin Efsitora is Noninferior to Degludec in Type 2 Diabetes without Previous Insulin Treatment

Click here to read this study in NEJM.

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

In topline phase 3 results, retatrutide lowered A1C more and reduced weight more than semaglutide 2 mg at 80 weeks

Higher coffee intake is associated with lower visceral fat despite similar body mass index

Adaptimmune’s Afami-cel is the first FDA-approved T-cell receptor therapy for synovial sarcoma

RelatedReports

A balance scale with a syringe on one side and silhouettes of varying body sizes on the other, symbolizing weight management and GLP-1 medications.

2MM Trial Briefs

In topline phase 3 results, retatrutide lowered A1C more and reduced weight more than semaglutide 2 mg at 80 weeks

October 29, 2026

A balance scale featuring a plate, an hourglass, and stacked papers, symbolizing nutrition, time management, and evidence-based practices.

Chronic Disease

Higher coffee intake is associated with lower visceral fat despite similar body mass index

September 8, 2026

Physical activity collage: a smiling middle-aged man in a track jacket beside a city bicycle and a teal resistance band

Chronic Disease

A healthy lifestyle may reduce risk of infection in patients with type 2 diabetes

September 2, 2026

Atrial fibrillation collage: an engraved heart with teal upper chambers, paper sparks and a dotted teal ribbon around it

Weekly Rewinds

2 Minute Medicine Rewind August 31, 2026

August 31, 2026

#VisualAbstract Telehealth vs In-Person Early Palliative Care for Patients with Advanced Lung Cancer

#VisualAbstract: Perioperative Durvalumab with Neoadju-vant Chemotherapy Improved Survival in Operable Bladder Cancer

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

#VisualAbstract: Insulin Efsitora is Noninferior to Degludec in Type 2 Diabetes without Previous Insulin Treatment

In topline phase 3 results, retatrutide lowered A1C more and reduced weight more than semaglutide 2 mg at 80 weeks

Higher coffee intake is associated with lower visceral fat despite similar body mass index

Adaptimmune’s Afami-cel is the first FDA-approved T-cell receptor therapy for synovial sarcoma

Ticagrelor monotherapy reduces bleeding risk compared to dual antiplatelet therapy for patients following coronary stenting

RelatedReports

In topline phase 3 results, retatrutide lowered A1C more and reduced weight more than semaglutide 2 mg at 80 weeks

Higher coffee intake is associated with lower visceral fat despite similar body mass index

A healthy lifestyle may reduce risk of infection in patients with type 2 diabetes

2 Minute Medicine Rewind August 31, 2026

Ticagrelor monotherapy reduces bleeding risk compared to dual antiplatelet therapy for patients following coronary stenting

#VisualAbstract Telehealth vs In-Person Early Palliative Care for Patients with Advanced Lung Cancer

#VisualAbstract: Perioperative Durvalumab with Neoadju-vant Chemotherapy Improved Survival in Operable Bladder Cancer

2MM+ All Access

Recent Reports

Get the app

Keep reading with 2 Minute Medicine+

Keep reading with 2 Minute Medicine+

The medical literature, distilled daily.

Membership benefits